Literature DB >> 10218524

Calcineurin inhibitors and cardiac hypertrophy.

T Force1, A Rosenzweig, G Choukroun, R Hajjar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10218524     DOI： 10.1016/S0140-6736(99)90016-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Cardiac signal transduction.

Authors:  K H Lee; R J Hajjar; T Matsui; G Choukroun; T L Force; A Rosenzweig
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.

Authors:  G Choukroun; R Hajjar; S Fry; F del Monte; S Haq; J L Guerrero; M Picard; A Rosenzweig; T Force
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 4.  Calcineurin and cardiac hypertrophy: where have we been? Where are we going?

Authors:  Benjamin J Wilkins; Jeffery D Molkentin
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

5.  Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy.

Authors:  S Haq; G Choukroun; Z B Kang; H Ranu; T Matsui; A Rosenzweig; J D Molkentin; A Alessandrini; J Woodgett; R Hajjar; A Michael; T Force
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

Review 6.  Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.

Authors:  David García-Vega; José Ramón González-Juanatey; Sonia Eiras
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.